For neuroprotection in AD, hesperidin has been noted to act by attenuating inflammation, caspase activation, raised p-Tau levels, and Aβ-42 and AchE overactivity in AlCl3-intoxicated rats [129, 130], and scopolamine-induced AD-like rat model [131]. This evidence concerns the gene MAPT and Alzheimer disease.